ArticleEndocrine, metabolic & immune disorders drug targets2026

Celastrol Attenuates FGF23 Expression in Osteoblasts by Inhibiting STAT3 Activation.

Jiawei Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.